| Fund ID | 805-5999276027 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Sands Capital Global Innovation Fund II, L.P. | Private Equity | $711.6M |
| Sands Capital Global Innovation Fund Ii-An, L.P. | Private Equity | $457.3M |
| Sands Capital Life Sciences Pulse Fund II, L.P. | Private Equity | $308.3M |
Sands Capital Life Sciences Pulse Fund III (de), L.P. reports $3.5 million in gross assets, among the top 87% of private funds by size.
Sands Capital Life Sciences Pulse Fund III (de), L.P. is managed by Sands Capital Ventures, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.